Smith & Nephew PLC

Common Name
Smith & Nephew
Country
United Kingdom
Sector
Healthcare
Industry
Medical Devices
Employees
17,000
Ticker
SN.
Exchange
LONDON STOCK EXCHANGE
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates i...

Smith & Nephew's Financial Statements Preview

Below are the financial statements of Smith & Nephew, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Revenue
5,810a
5,549a
5,215a
Cost of goods sold
-1,764a
-1,730a
-1,540a
Gross profit
4,046a
3,819a
3,675a
Selling, general and administrative expenses
-3,100a
-3,055a
-2,880a
Research and development expenses
-289a
-339a
-345a
Operating profit
657a
425a
450a
Interest income
24a
34a
14a
Interest expense
-145a
-132a
-80a
Other finance costs
-28a
-7a
-8a
Share of results of associates
-10a
-30a
-141a
Profit before taxation
498a
290a
235a
Taxation
-86a
-27a
-12a
Attributable profit for the year
412a
263a
223a
Download Data

Verified Sources Behind Smith & Nephew’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Smith & Nephew’s data sources below and access millions more through our Disclosure Search.

a. Smith & Nephew's Annual Report 2024
a. Smith & Nephew's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?